FCGR2A defines prognostic immune subtypes and drives tumor progression in hepatocellular carcinoma.
FCGR2A 决定肝细胞癌的预后免疫亚型并驱动肿瘤进展。
期刊:Frontiers in Immunology
影响因子:5.9
doi:10.3389/fimmu.2025.1641420
Zhong Deyuan, Liang Yuxin, Yan Hongtao, Chen Xing, Chen YaHui, Ma Shuoshuo, Su Yuhao, Wang Fei, Chen Xinpei, Yang Qinyan, Leng Zhengwei, Wang Ming, Huang Xiaolun